ORIGINAL_SOURCE SAMPLE_ALIAS IHEC_REFERENCE_EPIGENOME_IDENTIFIER SAMPLE_ACCESSION SAMPLE_TITLE ANONYMIZED_NAME BATCH BIOMATERIAL_PROVIDER BIOMATERIAL_TYPE COMMON_NAME DIFFERENTIATION_METHOD DIFFERENTIATION_STAGE DISEASE ENA-CHECKLIST LINE LINEAGE MEDIUM MOLECULE PASSAGE SAMPLE_DESCRIPTION SCIENTIFIC_NAME SEX TAXON_ID
CEMT_7 CEMT0007.gDNA CEMT0007 EGAN00001172015 CEMT_7, MCF10A, Mammary gland-Breast with pathology Mammary gland-Breast Fibrocystic Disease, genomic DNA MCF10A 1 Aparicio Cell Line human NA NA Mammary gland-Breast Fibrocystic Disease ERC000026 MCF10A A basal-like human breast cancer cell line Growth media: DMEM/F12 +5% horse serum (it also includes FGF (20 ug/ml), Hydrocortizone (0.5 mg/ml), Cholera Toxin (10 ug/ml), insulin (1 mg/ml), Pen/Strep 1%) genomic DNA 3 External Identifier:SA335, Original Source Name:CEMT_7, Anatomic Site:Mammary gland-Breast, Pathology Alias:Mammary gland-Breast Fibrocystic Disease, Cell Line Name:MCF10A, Original Source Id:34134 Homo sapiens Female 9606
CEMT_8 CEMT0008.gDNA CEMT0008 EGAN00001172016 CEMT_8, 184-hTert-L9, anatomic_site:Mammary gland-Breast, normal, genomic DNA 184-hTert-L9 1 Aparicio Cell Line human NA NA None ERC000026 184-hTert-L9 Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA genomic DNA 11 External Identifier:SA039, Original Source Name:CEMT_8, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L9, Original Source Id:34135 Homo sapiens Female 9606
CEMT_9 CEMT0009.gDNA CEMT0009 EGAN00001172017 CEMT_9, 184-hTert-L2, Mammary gland-Breast, Normal, genomic DNA 184-hTert-L2 1 Aparicio Cell Line human NA NA None ERC000026 184-hTert-L2 Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA genomic DNA 12 External Identifier:SA040, Original Source Name:CEMT_9, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L2, Original Source Id:34136 Homo sapiens Female 9606
CEMT_7 CEMT0007.tRNA CEMT0007 EGAN00001176008 CEMT_7, MCF10A, Mammary gland-Breast with pathology Mammary gland-Breast Fibrocystic Disease, total RNA MCF10A 1 Aparicio Cell Line human NA NA Mammary gland-Breast Fibrocystic Disease ERC000026 MCF10A A basal-like human breast cancer cell line Growth media: DMEM/F12 +5% horse serum (it also includes FGF (20 ug/ml), Hydrocortizone (0.5 mg/ml), Cholera Toxin (10 ug/ml), insulin (1 mg/ml), Pen/Strep 1%) total RNA 3 External Identifier:SA335, Original Source Name:CEMT_7, Anatomic Site:Mammary gland-Breast, Pathology Alias:Mammary gland-Breast Fibrocystic Disease, Cell Line Name:MCF10A, Original Source Id:34134 Homo sapiens Female 9606
CEMT_8 CEMT0008.tRNA CEMT0008 EGAN00001176009 CEMT_8, 184-hTert-L9, Mammary gland-Breast, normal, total RNA 184-hTert-L9 1 Aparicio Cell Line human NA NA None ERC000026 184-hTert-L9 Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA total RNA 11 External Identifier:SA039, Original Source Name:CEMT_8, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L9, Original Source Id:34135 Homo sapiens Female 9606
CEMT_9 CEMT0009.tRNA CEMT0009 EGAN00001176010 CEMT_9, 184-hTert-L2, Mammary gland-Breast, Normal, total RNA 184-hTert-L2 1 Aparicio Cell Line human NA NA None ERC000026 184-hTert-L2 Normal mammary epithelial cell line. L2 and L9 are two clones selected from the original 184-hTERT line, which was a mixed population. 184-hTERTs are predisposed to gain chromosome 20 upon continued passage in culture. The L2 clone gains chromosome 20 much more rapidly than L9 or other clones that have been examined. Growth media: MEBM+MEGM (supplements and growth factors, note: GA1000 also included as part of the supplements was NOT used in the growth media) all from LONZA total RNA 12 External Identifier:SA040, Original Source Name:CEMT_9, Anatomic Site:Mammary gland-Breast, Cell Line Name:184-hTert-L2, Original Source Id:34136 Homo sapiens Female 9606


ORIGINAL_SOURCE SAMPLE_ALIAS IHEC_REFERENCE_EPIGENOME_IDENTIFIER SAMPLE_ACCESSION SAMPLE_TITLE ANONYMIZED_NAME BIOMATERIAL_PROVIDER BIOMATERIAL_TYPE COLLECTION_METHOD COMMON_NAME DISEASE DONOR_AGE DONOR_ETHNICITY DONOR_HEALTH_STATUS DONOR_ID DONOR_SEX MOLECULE REFERENCE_BIOSAMPLE_URI SAMPLE_DESCRIPTION SCIENTIFIC_NAME TAXON_ID TISSUE_DEPOT TISSUE_TYPE
CEMT_45 CEMT0045.gDNA CEMT0045 Primary Tissue from SW-TTP-177 (55, Male, Diseased Thyroid sample with donor health condition: Thyroid Goiter) SW-TTP-177 Wiseman lab Primary Tissue Gross Dissection human Thyroid Goiter 55 Unknown Thyroid Goiter SW-TTP-177 Male genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-177 (55, Male, Diseased Thyroid sample with donor health condition: Thyroid Goiter) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid
CEMT_44 CEMT0044.gDNA CEMT0044 Primary Tissue from SW-TTP-177 (55, Male, Normal Thyroid sample with donor health condition: Thyroid Goiter) SW-TTP-177 Wiseman lab Primary Tissue Gross Dissection human None 55 Unknown SW-TTP-177 Male genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-177 (55, Male, Normal Thyroid sample with donor health condition: Thyroid Goiter) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid
CEMT_43 CEMT0043.gDNA CEMT0043 Primary Tissue from SW-TTP-170 (46, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) SW-TTP-170 Wiseman lab Primary Tissue Gross Dissection human Thyroid Adenoma-Follicular 46 Unknown Thyroid Adenoma-Follicular SW-TTP-170 Female genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-170 (46, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid
CEMT_42 CEMT0042.gDNA CEMT0042 Primary Tissue from SW-TTP-170 (46, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) SW-TTP-170 Wiseman lab Primary Tissue Gross Dissection human None 46 Unknown SW-TTP-170 Female genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-170 (46, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid
CEMT_4 CEMT0040.gDNA CEMT0040 Primary Tissue from SW-TTP-156 (67, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) SW-TTP-156 Wiseman lab Primary Tissue Gross Dissection human None 67 Unknown SW-TTP-156 Female genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-156 (67, Female, Normal Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid
CEMT_41 CEMT0041.gDNA CEMT0041 Primary Tissue from SW-TTP-156 (67, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) SW-TTP-156 Wiseman lab Primary Tissue Gross Dissection human Thyroid Adenoma-Follicular 67 Unknown Thyroid Adenoma-Follicular SW-TTP-156 Female genomic DNA __TO_BE_GENERATED__ Primary Tissue from SW-TTP-156 (67, Female, Diseased Thyroid sample with donor health condition: Thyroid Adenoma-Follicular) from Wiseman lab Homo sapiens 9606 Thyroid Thyroid

ORIGINAL_SOURCE SAMPLE_ALIAS SAMPLE_ACCESSION SAMPLE_TITLE ANONYMIZED_NAME BIOMATERIAL_PROVIDER BIOMATERIAL_TYPE CELL_TYPE COMMON_NAME DISEASE DONOR_AGE DONOR_ETHNICITY DONOR_HEALTH_STATUS DONOR_ID DONOR_SEX ENA-CHECKLIST IHEC REFERENCE EPIGENOME IDENTIFIER MARKERS MOLECULE PASSAGE_IF_EXPANDED SAMPLE_DESCRIPTION SCIENTIFIC_NAME TAXON_ID
CEMT_1 CEMT0001.gDNA EGAN00001172011 CEMT_1, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 230-56 Connors/Weng/Eaves Lab Primary Cell CD19+ cells (B lymphocytes) human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 78 Caucasian Diseased 230-56 Male ERC000026,ERC000026 CEMT0001 CD19+ genomic DNA NA External Identifier:B32840, Original Source Name:CEMT_1, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:230-56, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:30730 Homo sapiens 9606
CEMT_4 CEMT0004.gDNA EGAN00001172012 CEMT_4, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 231-73 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 74 Caucasian Diseased 231-73 Male ERC000026,ERC000026 CEMT0004 CD19+ genomic DNA NA External Identifier:B32942, Original Source Name:CEMT_4, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-73, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33649 Homo sapiens 9606
CEMT_5 CEMT0005.gDNA EGAN00001172013 CEMT_5, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 231-74 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 68 Caucasian Diseased 231-74 Female ERC000026,ERC000026 CEMT0005 CD19+ genomic DNA NA External Identifier:B32943, Original Source Name:CEMT_5, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-74, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33650 Homo sapiens 9606
CEMT_6 CEMT0006.gDNA EGAN00001172014 CEMT_6,Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 232-14 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 60 Caucasian Diseased 232-14 Male ERC000026,ERC000026 CEMT0006 CD19+ genomic DNA NA External Identifier:B32974, Original Source Name:CEMT_6, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:232-14, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33651 Homo sapiens 9606
CEMT_1 CEMT0001.tRNA EGAN00001176004 CEMT_1, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA 230-56 Connors/Weng/Eaves Lab Primary Cell CD19+ cells (B lymphocytes) human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 78 Caucasian Diseased 230-56 Male ERC000026 CEMT0001 CD19+ total RNA NA External Identifier:B32840, Original Source Name:CEMT_1, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:230-56, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:30730 Homo sapiens 9606
CEMT_4 CEMT0004.tRNA EGAN00001176005 CEMT_4, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA 231-73 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 74 Caucasian Diseased 231-73 Male ERC000026 CEMT0004 CD19+ total RNA NA External Identifier:B32942, Original Source Name:CEMT_4, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-73, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33649 Homo sapiens 9606
CEMT_5 CEMT0005.tRNA EGAN00001176006 CEMT_5, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA 231-74 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 68 Caucasian Diseased 231-74 Female ERC000026 CEMT0005 CD19+ total RNA NA External Identifier:B32943, Original Source Name:CEMT_5, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:231-74, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33650 Homo sapiens 9606
CEMT_6 CEMT0006.tRNA EGAN00001176007 CEMT_6, Blood-Peripheral with pathology Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, total RNA 232-14 Connors/Weng/Eaves Lab Primary Cell B cells human Blood-Peripheral Leukemia-Chronic lymphocytic leukemia 60 Caucasian Diseased 232-14 Male ERC000026 CEMT0006 CD19+ total RNA NA External Identifier:B32974, Original Source Name:CEMT_6, Anatomic Site:Blood-Peripheral, Pathology Alias:Blood-Peripheral Leukemia-Chronic lymphocytic leukemia, Patient Identifier:232-14, Biomaterial Provider:Connors/Weng/Eaves Lab, Original Source Id:33651 Homo sapiens 9606